The effect of hormone replacement therapy on arterial distensibility and compliance in perimenopausal women: A 2-year randomised trial

Atherosclerosis

Volumn 152, Issue 1, 2000, Pages 149-157

  Westendorp, I C D ^a   De Kleijn, M J J ^b   Bots, M L ^a,b   Bak, A A A ^b   Planellas, J ^c   Coelingh Bennink, H J T ^c   Hofman, A ^a   Grobbee, D E ^a,b   Witteman, J C M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c NV ORGANON   (Netherlands)

Author keywords

Arterial compliance; Arterial distensibility; Arterial stiffness; Cardiovascular disease; Hormone replacement therapy; Oestradiol; Women

Indexed keywords

DESOGESTREL; ESTRADIOL; NORGESTREL;

ADULT; ARTERY COMPLIANCE; ARTICLE; B SCAN; CALCULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMMON CAROTID ARTERY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RIGIDITY; SYSTOLIC BLOOD PRESSURE;

ADULT; CARDIOVASCULAR DISEASES; CAROTID ARTERY, COMMON; COMPLIANCE; CONFIDENCE INTERVALS; DESOGESTREL; DOUBLE-BLIND METHOD; ELASTICITY; ESTRADIOL; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; PROBABILITY; REFERENCE VALUES; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 0034283525     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00438-4     Document Type: Article

References (58)

1. Stampfer M.J., Colditz G.A. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev. Med. 20:1991;47-63.
2. Grady D., Rubin S.M., Petitti D.B., et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann. Intern. Med. 117:1992;1016-1037.
3. Barrett-Connor E., Grady D. Hormone replacement therapy, heart disease, and other considerations. Annu. Rev. Public Health. 19:1998;55-72.
4. Magness R.R., Rosenfeld C.R. Local and systemic estradiol-17 beta: effects on uterine and systemic vasodilation. Am. J. Physiol. 256:1989;E536-E542.
5. Williams J.K., Adams M.R., Klopfenstein H.S. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation. 81:1990;1680-1687.
6. Jiang C.W., Sarrel P.M., Lindsay D.C., Poole-Wilson P.A., Collins P. Endothelium-independent relaxation of rabbit coronary artery by 17 beta-oestradiol in vitro. Br. J. Pharmacol. 104:1991;1033-1037.
7. Sudhir K., Chou T.M., Mullen W.L., et al. Mechanisms of estrogen-induced vasodilation: in vivo studies in canine coronary conductance and resistance arteries. J. Am. Coll. Cardiol. 26:1995;807-814.
8. Riedel M., Rafflenbeul W., Lichtlen P. Ovarian sex steroids and atherosclerosis. Clin. Invest. 71:1993;406-412.
9. Beldekas J.C., Smith B., Gerstenfeld L.C., Sonenshein G.E., Franzblau C. Effects of 17 beta-estradiol on the biosynthesis of collagen in cultured bovine aortic smooth muscle cells. Biochemistry. 20:1981;2162-2167.
10. Fischer G.M., Swain M.L. Effects of estradiol and progesterone on the increased synthesis of collagen in atherosclerotic rabbit aortas. Atherosclerosis. 54:1985;177-185.
11. Williams J.K., Adams M.R., Herrington D.M., Clarkson T.B. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J. Am. Coll. Cardiol. 20:1992;452-457.
12. Gilligan D.M., Badar D.M., Panza J.A., Quyyumi A.A., Cannon R.R. Acute vascular effects of estrogen in postmenopausal women. Circulation. 90:1994;786-791.
13. McCrohon J.A., Adams M.R., McCredie R.J., et al. Hormone replacement therapy is associated with improved arterial physiology in healthy post-menopausal women. Clin. Endocrinol. 45:1996;435-441.
14. Lieberman E.H., Gerhard M.D., Uehata A., et al. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann. Intern. Med. 121:1994;936-941.
15. New G., Timmins K.L., Duffy S.J., et al. Long-term estrogen therapy improves vascular function in male to female transsexuals. J. Am. Coll. Cardiol. 29:1997;1437-1444.
16. McCrohon J.A., Walters W.A., Robinson J.T., et al. Arterial reactivity is enhanced in genetic males taking high dose estrogens. J. Am. Coll. Cardiol. 29:1997;1432-1436.
17. Penotti M., Nencioni T., Gabrielli L., Farina M., Castiglioni E., Polvani F. Blood flow variations in internal carotid and middle cerebral arteries induced by postmenopausal hormone replacement therapy. Am. J. Obstet. Gynecol. 169:1993;1226-1232.
18. Lau T.K., Chung T.K., Haines C.J. A preliminary study on the effect of hormone replacement therapy on peripheral flow velocity in postmenopausal women. Maturitas. 26:1997;53-56.
19. Jackson S., Vyas S. A double-blind, placebo controlled study of postmenopausal oestrogen replacement therapy and carotid artery pulsatility index. Br. J. Obstet. Gynaecol. 105:1998;408-412.
20. Luckas M.J., Gleeve T., Biljan M.M., et al. The effect of progestagens on the carotid artery pulsatility index in postmenopausal women on oestrogen replacement therapy. Eur. J. Obstet. Gynecol. Reprod. Biol. 76:1998;221-224.
21. Liang Y.L., Teede H., Shiel L.M., et al. Effects of oestrogen and progesterone on age-related changes in arteries of postmenopausal women. Clin. Exp. Pharmacol. Physiol. 24:1997;457-459.
22. Hayward C.S., Knight D.C., Wren B.G., Kelly R.P. Effect of hormone replacement therapy on non-invasive cardiovascular haemodynamics. J. Hypertens. 15:1997;987-993.
23. Rajkumar C., Ba K., Cameron J.D., et al. Hormonal therapy increases arterial compliance in postmenopausal women. J. Am. Coll. Cardiol. 30:1997;350-356.
24. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18:1972;499-502.
25. Westendorp I.C.D., Bots M.L., Grobbee D.E., et al. Menopausal status and distensibility of the common carotid artery. Arterioscler. Thromb. Vasc. Biol. 19:1999;713-717.
26. Hoeks A.P., Brands P.J., Smeets F.A., Reneman R.S. Assessment of the distensibility of superficial arteries. Ultrasound Med. Biol. 16:1990;121-128.
27. Reneman R.S., van Merode T., Brands P.J., Hoeks A.P. Inhomogeneities in arterial wall properties under normal and pathological conditions. J. Hypertens. Suppl. 10:1992;S35-S39.
28. Kool M.J., van Merode T., Reneman R.S., Hoeks A.P., Struyker Boudier H.A., Van Bortel L.M. Evaluation of reproducibility of a vessel wall movement detector system for assessment of large artery properties. Cardiovasc. Res. 28:1994;610-614.
29. Reneman R.S., van Merode T., Hick P., Muytjens A.M., Hoeks A.P. Age-related changes in carotid artery wall properties in men. Ultrasound Med. Biol. 12:1986;465-471.
30. Nichols W.W., O'Rourke M.F. McDonald's Blood Flow in Arteries. 3rd edition :1990;Edward Arnold, London.
31. Willekes C., Hoogland H.J., Keizer H.A., Hoeks A.P., Reneman R.S. Female sex hormones do not influence arterial wall properties during the normal menstrual cycle. Clin. Sci. (Colch). 92:1997;487-491.
32. Jiang C.W., Sarrel P.M., Lindsay D.C., Poole-Wilson P.A., Collins P. Progesterone induces endothelium-independent relaxation of rabbit coronary artery in vitro. Eur. J. Pharmacol. 211:1992;163-167.
33. Rosano GM, Sarrel PM, Chierchia SL. Medroxyprogesterone acetate but not natural progesteron reverses the effects of estradiol 17b upon exercise induced myocardial ischemia. Proceedings of the 8th International Congress on Menopause 1996:F126.
34. Register T.C., Adams M.R., Golden D.L., Clarkson T.B. Conjugated equine estrogens alone, but not in combination with medroxyprogesterone acetate, inhibit aortic connective tissue remodeling after plasma lipid lowering in female monkeys. Arterioscler. Thromb. Vasc. Biol. 18:1998;1164-1171.
35. Resnik R., Brink G.W., Plumer M.H. The effect of progesterone on estrogen-induced uterine blood flow. Am. J. Obstet. Gynecol. 128:1977;251-254.
36. Hillard T.C., Bourne T.H., Whitehead M.I., Crayford T.B., Collins W.P., Campbell S. Differential effects of transdermal estradiol and sequential progestogens on impedance to flow within the uterine arteries of postmenopausal women. Fertil. Steril. 58:1992;959-963.
37. Marsh M.S., Bourne T.H., Whitehead M.I., Collins W.P., Campbell S. The temporal effect of progestogen on uterine artery pulsatility index in postmenopausal women receiving sequential hormone replacement therapy. Fertil. Steril. 62:1994;771-774.
38. Bourne T., Hillard T.C., Whitehead M.I., Crook D., Campbell S. Oestrogens, arterial status, and postmenopausal women. Lancet. 335:1990;1470-1471.
39. Grodstein F. Invited commentary: can selection bias explain the cardiovascular benefits of estrogen replacement therapy? Am J Epidemiol 1996;143:979-982; discussion 983-4.
40. McGrath B.P., Liang Y.L., Teede H., Shiel L.M., Cameron J.D., Dart A. Age-related deterioration in arterial structure and function in postmenopausal women: impact of hormone replacement therapy. Arterioscler. Thromb. Biol. 18:1998;1149-1156.
41. Stratos C., Stefanadis C., Kallikazaros I., Boudoulas H., Toutouzas P. Ascending aorta distensibility abnormalities in hypertensive patients and response to nifedipine administration. Am. J. Med. 93:1992;505-512.
42. Matthews K.A., Wing R.R., Kuller L.H., Meilahn E.N., Plantinga P. Influence of the perimenopause on cardiovascular risk factors and symptoms of middle-aged healthy women. Arch. Intern. Med. 154:1994;2349-2355.
43. Barentsen R. The climacteric in The Netherlands: a review of Dutch studies on epidemiology, attitudes and use of hormone replacement therapy. Eur. J. Obstet. Gynecol. Reprod. Biol. 64:1996;S7-S11.
44. Anonymous. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Proge (PEPI) Trial. The Writing Group for the PEPI Trial [see comments] [published erratum appears in JAMA 1995 Dec 6;274(21):1676]. Jama 1994;273:199-208.
45. Anonymous. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Proge (PEPI) Trial. The Writing Group for the PEPI Trial [see comments] [published erratum appears in JAMA 1995 Dec 6;274(21):1676]. Jama 1994;273:199-208.
46. Anonymous. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Proge (PEPI) Trial. The Writing Group for the PEPI Trial [see comments] [published erratum appears in JAMA 1995 Dec 6;274(21):1676]. Jama 1994;273:199-208.
47. Arnett D.K., Evans G.W., Riley W.A. Arterial stiffness: a new cardiovascular risk factor? Am. J. Epidemiol. 140:1994;669-682.
48. Hodes R.J., Lakatta E.G., McNeil C.T. Another modifiable risk factor for cardiovascular disease? Some evidence points to arterial stiffness. J. Am. Geriatr. Soc. 43:1995;581-582.
49. Wada T., Kodaira K., Fujishiro K., et al. Correlation of ultrasound-measured common carotid artery stiffness with pathological findings. Arterioscler. Thromb. 14:1994;479-482.
50. Megnien J.L., Simon A., Denarie N., et al. Aortic stiffening does not predict coronary and extracoronary atherosclerosis in asymptomatic men at risk for cardiovascular disease. Am. J. Hypertens. 11:1998;293-301.
51. Glasser S.P., Arnett D.K., McVeigh G.E., et al. Vascular compliance and cardiovascular disease: a risk factor or a marker? Am. J. Hypertens. 10:1997;1175-1189.
52. Vaitkevicius P.V., Fleg J.L., Engel J.H., et al. Effects of age and aerobic capacity on arterial stiffness in healthy adults. Circulation. 88:1993;1456-1462.
53. Hansen F., Mangell P., Sonesson B., Lanne T. Diameter and compliance in the human common carotid artery - variations with age and sex. Ultrasound Med. Biol. 21:1995;1-9.
54. Riley W.A., Freedman D.S., Higgs N.A., Barnes R.W., Zinkgraf S.A., Berenson G.S. Decreased arterial elasticity associated with cardiovascular disease risk factors in the young. Bogalusa Heart Study. Arteriosclerosis. 6:1986;378-386.
55. Alva F., Samaniego V., Gonzalez V., Moguel R., Meaney E. Structural and dynamic changes in the elastic arteries due to arterial hypertension and hypercholesterolemia. Clin. Cardiol. 16:1993;614-618.
56. Taquet A., Bonithon-Kopp C., Simon A., et al. Relations of cardiovascular risk factors to aortic pulse wave velocity in asymptomatic middle-aged women. Eur. J. Epidemiol. 9:1993;298-306.
57. Hirai T., Sasayama S., Kawasaki T., Yagi S. Stiffness of systemic arteries in patients with myocardial infarction. A noninvasive method to predict severity of coronary atherosclerosis. Circulation. 80:1989;78-86.
58. Lehmann E.D., Hopkins K.D., Jones R.L., Rudd A.G., Goslings R.G. Aortic distensibility in patients with cerebrovascular disease. Clin. Sci. 89:1995;247-253.